Concepedia
Statistics
Publications
8
Citations
178
H-Index
Active since
2019
Affiliations
Tsinghua University(Current)
University Town of Shenzhen
Shenzhen Bay Laboratory
Southern University of Science and Technology
Shenzhen Institute for Drug Control
Zhichao Shi is an author at Tsinghua University specializing in oncology, drug discovery, and medicinal chemistry.
Publications per year
2019–2024
Dual inhibitors of DNMT and HDAC induce viral mimicry to induce antitumour immunity in breast cancer
Wenjun Huang, Qingyun Zhu, Zhichao Shi et al. · Cell Death Discovery · 2024 · 55 citations · Full text
Life Sciences, Immunology, Oncology +17
Design, synthesis and evaluation of novel ErbB/HDAC multitargeted inhibitors with selectivity in EGFRT790M mutant cell lines
Lei Zhao, Tingting Fan, Zhichao Shi et al. · European Journal of Medicinal Chemistry · 2021 · 23 citations · Full text
Pharmacy, Medicinal Chemistry, Oncology +14
Synthesis of Diversely Substituted Imidazolidines <i>via</i> [3+2] Cycloaddition of 1,3,5‐Triazinanes with Donor‐Acceptor Aziridines and Their Anti‐Tumor Activity
Zhichao Shi, Tingting Fan, Xun Zhang et al. · Advanced Synthesis & Catalysis · 2021 · 21 citations
Pharmacy, Medicinal Chemistry, Oncology +6
Discovery of the PARP (poly ADP-ribose polymerase) inhibitor 2-(1-(4,4-difluorocyclohexyl)piperidin-4-yl)-1H-benzo[d]imidazole-4-carboxamide for the treatment of cancer
Lin Tang, Weibin Wu, Cunlong Zhang et al. · Bioorganic Chemistry · 2021 · 18 citations
Medicine, Oncology, Pharmacology +8
Design, synthesis and anti-tumor evaluation of 1,2,4-triazol-3-one derivatives and pyridazinone derivatives as novel CXCR2 antagonists
Xun Zhang, Jingyi Luo, Qinyuan Li et al. · European Journal of Medicinal Chemistry · 2021 · 17 citations · Full text
Medicine, Medicinal Chemistry, Oncology +8
1–5 of 8